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ABSTRACT
HMGB1 is a ubiquitous non-histone protein, which
biological effects depend on its expression and sub-
cellular location. Inside the nucleus, HMGB1 is en-
gaged in many DNA events such as DNA repair,
transcription and telomere maintenance. HMGB1 has
been reported to bind preferentially to bent DNA
as well as to noncanonical DNA structures like 4-
way junctions and, more recently, to G-quadruplexes.
These are four-stranded conformations of nucleic
acids involved in important cellular processes, in-
cluding telomere maintenance. In this frame, G-
quadruplex recognition by specific proteins repre-
sents a key event to modulate physiological or patho-
logical pathways. Herein, to get insights into the
telomeric G-quadruplex DNA recognition by HMGB1,
we performed detailed biophysical studies comple-
mented with biological analyses. The obtained re-
sults provided information about the molecular deter-
minants for the interaction and showed that the struc-
tural variability of human telomeric G-quadruplex
DNA may have significant implications in HMGB1
recognition. The biological data identified HMGB1
as a telomere-associated protein in both telomerase-
positive and -negative tumor cells and showed that
HMGB1 gene silencing in such cells induces telom-
ere DNA damage foci. Altogether, these findings
provide a deeper understanding of telomeric G-
quadruplex recognition by HMGB1 and suggest that
this protein could actually represent a new target for
cancer therapy.
INTRODUCTION
Mechanisms of regulation of telomere maintenance are the
subject of extensive investigation, because of their direct
relation with genome stability, aging and cancer (1). The
telomere is a highly specialized functional structure located
at the end of eukaryotic chromosomes whose main role is
to maintain genomic stability. In normal cells, telomere is
shortened during every DNA replication until its loss even-
tually triggers apoptosis (2). It consists of tandem repeats
of a DNA sequence and a number of associated proteins.
In humans, telomeric DNA is a double-stranded array of
TTAGGG repeats, which terminates in a 3′ single-stranded
G-rich overhang capable of forming noncanonical struc-
tures known as G-quadruplexes (G4s) (3,4). Telomeric G4s
have been shown to have regulatory roles in telomere exten-
sion and maintenance (5). Indeed, G4 formation interferes
with the activity of telomerase, a ribonucleoprotein com-
plex overexpressed in ∼85% of cancers that elongates the
single-stranded telomeric overhang, thus leading to cell im-
mortality (6).
Besides telomerase, several proteins have been shown to
interact with telomeric DNA with different biological func-
tions (7,8). Some of these proteins are able to unfold the
G4 structure promoting telomerase activity, while others
hinder the interaction between telomeric DNA and telom-
erase (9,10). Recently, through a chemoproteomic-driven
approach, some of us have identified novel binding part-
ners of human telomeric G4 DNA, thus suggesting a previ-
ously unknown role for these proteins at telomeric level (11).
Among the identified proteins is the nuclear protein High
Mobility Group B1 (HMGB1), a highly abundant verte-
brate nuclear protein involved in a number of DNA activity-
associated events (12,13). Besides G4 DNA, HMGB1 binds
with high affinity to other noncanonical DNA structures
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like 4-way junctions and hemicatenated DNA loops. In ad-
dition, it binds to B-form DNA without sequence specificity
and causes distortion of the DNA helix, facilitating the in-
teraction of DNA with other nuclear proteins (12). Thus,
HMGB1 acts as a DNA chaperone in transcription, repli-
cation, recombination, and repair. When released in the ex-
tracellular space, HMGB1 accomplishes its function by ac-
tivating signaling pathways in combination with other cy-
tokines and chemokines. Its high levels are usually associ-
ated with tumor development, proliferation, invasion and
metastasis, but paradoxically HMGB1 has also been re-
ported to promote tumor suppression (14,15).
In parallel to its identification as telomeric (and later also
as non-telomeric) G4-interacting protein (11,16), HMGB1
was found to be involved in the regulation of telomere
homeostasis by an independent research group (17). In ad-
dition, previous results clearly showed that knockout of
HMGB1 gene in mouse embryonic fibroblasts resulted in
reduced telomerase activity and telomere dysfunction (18).
Moreover, purified HMGB1 was unable to enhance telom-
erase activity in vitro, indicating that this effect was not a
consequence of a direct binding of the protein to active
telomerase complex (18).
HMGB1 is structurally composed by two tandem box do-
mains, box-A and box-B, connected by a basic linker region.
Solution structures of the isolated domains determined by
NMR are reported in the protein data bank (box-A, PDB
codes: 2RTU (19) and 2LY4 (20); box-B, PDB code: 1HMF
(21)). The two box domains present the same global fold
with a L-shaped architecture, containing a short arm com-
prising helices I and II, and a long arm comprising helix III
and the N-terminal extended strand. However, the different
relative helices orientation and the low sequence homology
(about 29%) account for different ways of binding to DNA
of the two domains.
NMR relaxation measurements, performed on the full-
length protein, indicated that the two box domains behave
as rigid structures connected by a highly flexible linker re-
gion and do not interact with each other (22). This was
also confirmed by the family of NMR structures of the
free HMGB1 full-length protein (PDB code: 2YRQ) that
is composed by a bundle of conformations with differ-
ent relative inter-domain orientations. Unfortunately, the
high interdomain flexibility of HMGB1 and the lack of
any DNA-sequence specificity preclude the generation of
a well-defined and stable complex and prevent the struc-
ture determination of a full-length protein/DNA complex
both by X-ray crystallography and NMR. Nevertheless,
structures of complexes of the isolated box domains or of
chimeric proteins with duplex DNA are available in the pro-
tein data bank, namely, the X-ray structure of isolated box-
A in complex with a duplex DNA (PDB code: 4QR9) (23),
and the NMR structure of the complex formed by a hybrid
HMGB1 protein with duplex-DNA (PDB code: 2GZK)
(24). In the latter, box-A was replaced by the HMG box of
the sequence-specific transcription factor SRY. The analy-
sis of these structures revealed that the basis of the B-DNA
distortion induced by the binding of HMG boxes is the in-
tercalation of bulky hydrophobic amino acid side-chains be-
tween successive base-pairs.
G4 DNA structures differ considerably from the double
helical structure of B-DNA in the number and orientation
of strands, groove width, and presence of loops (25). Such
substantial structural differences obviously result in consid-
erable differences in the shape and electrostatic potential of
the DNA molecules that are expected to strongly influence
protein recognition.
In this context, this work provides a detailed biophysical
examination of the interaction between HMGB1 and the
G4-forming 26-mer truncation of human telomeric DNA
d[(TTAGGG)4TT]. We mainly focused on the unimolecu-
lar parallel-stranded G4 structure adopted by this sequence
(hereafter referred to as TelG4-up, Figure 1A), which was
previously used as a probe to fish out HMGB1 from a nu-
clear protein matrix (11), and that seems to be the most fa-
vored under cell-mimicking conditions (26). Since the hu-
man telomeric G4s are structurally heterogeneous and in or-
der to evaluate the possible role of loops in the G4/protein
recognition, experiments were also performed on the hybrid
[3+1] G4 conformation adopted by such telomeric DNA
(TelG4-uh, Figure 1B), and on the tetramolecular paral-
lel G4 structure formed by the d(TTAGGGT) sequence
(TelG4-tp, Figure 1C). The results of our biophysical stud-
ies provide useful insights into the structural and energetic
aspects of the HMGB1/G4 recognition, including the role
of the two protein domains in the molecular recognition
of these DNA structures and the G4 structural determi-
nants for an optimal interaction. To shed light on the pos-
sible interaction mechanism occurring between HMGB1
and TelG4-up, models of the complex have been generated
by performing docking calculations driven by experimental
data. Biological analyses have been also performed to ob-
serve the telomeric localization of HMGB1 as well as the
effect of silencing of HMGB1 encoding gene at the telom-
eric level in both telomerase-positive and -negative tumor
cell lines.
MATERIALS AND METHODS
Protein expression and purification
The plasmids encoding the three protein constructs were
cloned as described in Supplementary Material. GST-
fused HMGB11-166 (residues 1–166) and GST-fused box-
B (residues 98–166) constructs were both expressed in Es-
cherichia coli C41(DE3) strain cells, whereas GST-fused
box-A (residues 1–81) construct was expressed in E. coli
BL21(DE3) Codon Plus RIPL (simply RIPL) cells (Sup-
plementary Figures S1–S3, Supplementary Material). The
pETG-30A-transformed cells were cultured in 13C,15N-
enriched Silantes OD2 medium supplied with 0.1 mg ml−1
ampicillin (and even 34 g ml−1 chloramphenicol in the
case of RIPL cells), grown at 310 K until A600 nm reached
0.6, then induced with 1 mM IPTG. Cells were further let
grow at 298 K overnight (for C41(DE3) cells) and at 310
K for 3 h (for RIPL cells), then harvested by centrifuga-
tion at 7500 rpm for 15 min at 277 K. The extraction and
purification steps were performed with the same protocol
for all the three constructs. The bacterial pellet was resus-
pended in 50 mM Tris–HCl, pH 8.0, 500 mM NaCl buffer
(lysis buffer, 45 ml for liter of culture) and incubated at 277
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Figure 1. Representation of (A) unimolecular parallel (TelG4-up), (B) unimolecular hybrid (TelG4-uh) and (C) tetramolecular parallel (TelG4-tp) G4
structures formed by truncations of human telomeric DNA sequence.
on ice for 12 cycles, alternating 30 s of pulse and 180 s of
resting, and then ultracentrifuged at 40 000 rpm at 277 K
for 40 min. The supernatant was again incubated on ice and
treated with polyethylenimine (PEI): small fractions of ∼5%
(w/v) PEI solution (pH 7.9) were gradually added up to
reach a PEI concentration of 0.8% w/v in the suspension,
which was then centrifuged at 8000 rpm for 20 min. The
precipitate of nucleic acids was removed, whereas the su-
pernatant was treated with aliquots of solid (NH4)2SO4 up
to 70% (w/v) of saturation, upon stirring at 277 K. Again,
the suspension was centrifuged at 10 000 rpm for 30 min.
The supernatant was discarded, whereas the precipitate was
washed three times with a 70% (w/v) saturated (NH4)2SO4
solution. The final protein pellet was stored at 277 K. The
purification steps before and after TEV cleavage were car-
ried out by a Ni-affinity chromatography. The GST-fused
protein pellet was resuspended in 50 mM Tris–HCl, pH 8.0,
500 mM NaCl, 5 mM imidazole buffer (binding buffer, 50
ml for liter of culture) and loaded onto a pre-equilibrated
5 ml Ni-column. After washing with the binding buffer,
the elution was carried out using 20 mM imidazole. Frac-
tions of pure GST-fused protein were combined and buffer-
exchanged to 50 mM Tris–HCl, pH 8.0, 150 mM NaCl. The
solution was concentrated down to 2 mg ml−1 of GST-fused
protein, then supplied with 0.5 mM EDTA and 1.0 mM
DTT. A stock of glycerolized TEV solution was added and
the mixture incubated at 298 K overnight. After TEV cleav-
age, 5 mM imidazole was added to the solution which was
then loaded onto a pre-equilibrated 5 ml Ni-column. The
protein (without the GST fragment) was eluted with 40 mM
imidazole. The solution of protein was then further purified
by gel filtration using a Superdex 75 16/60 column. The pro-
tein was eluted in 10 mM KH2PO4 buffer, pH 7.0, contain-
ing 70 mM KCl, and the fractions containing pure protein
were identified by an SDS-PAGE and combined. The solu-
tion was concentrated to 4.5 M, supplied with 250 mM
LiCl and 10% D2O, then stored at 277 K.
Preparation of DNA samples
DNA oligonucleotides were chemically synthesized
on an ABI 394 DNA/RNA synthesizer (Applied
Biosystem) at 5 or 1 mol scale, using the standard
-cyanoethylphosphoramidite solid phase chemistry as
described elsewhere (27). In particular, the following
oligonucleotides were synthesized: d[(TTAGGG)4TT] and
d(TTAGGGT), corresponding to two different truncations
of human telomeric DNA sequence. After synthesis, the
oligomers were detached from the support and deprotected
by treatment with concentrated aqueous ammonia at
55◦C for 17 h. The combined filtrates and washings were
concentrated under reduced pressure, dissolved in H2O,
and purified by high-performance liquid chromatogra-
phy (HPLC) employing standard protocols. The isolated
oligomers were proved to be >98% pure by NMR. The
concentration of oligonucleotides was determined by UV
adsorption measurements at 90◦C using appropriate molar
extinction coefficient values ε ( = 260 nm), calculated by
the nearest-neighbor model (28). All G4s were prepared
in 10 mM KH2PO4 buffer containing 70 mM KCl, pH
7.0. Samples were then heated at 90◦C for 5 min, grad-
ually cooled to room temperature overnight, and finally
incubated at 4◦C for 24 h, before data acquisition. The
G4 parallel arrangement of the 26-mer telomeric sequence
(TelG4-up) was prepared and checked as previously
described (29,30).
Circular dichroism (CD) experiments
CD experiments were recorded on a Jasco J-815 spectropo-
larimeter equipped with a PTC-423S/15 Peltier tempera-
ture controller. All the experiments were carried out in 10
mM KH2PO4 buffer (pH 7.0) containing 70 mM KCl. CD
spectra were recorded at 20◦C in a quartz cuvette with 1
mm path length in the 190–340 nm wavelength range and
averaged over three scans. A concentration of 1 M was
used for both G4s and proteins. The scan rate was set
to 100 nm/min, with 1 s response time and 1 nm band-
width. Buffer baseline was subtracted from each spectrum.
CD melting experiments of G4s in the absence or presence
of 1 molar equiv. of HMGB11–166 or box-A were carried
out at 1◦C/min heating rate by following the CD signal
at the wavelength of maximum intensity in the spectral re-
gion where only the G4 chromophores absorb (263 nm for
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ing temperatures were determined from curve fitting using
Origin 7.0 (OriginLab, Northampton, MA, USA).
NMR measurements
NMR titrations of the HMGB11-166 protein and of the iso-
lated box domains (A and B) with G4 DNA were performed
at 298 K in buffered solution: 10 mM KH2PO4, 70 mM KCl,
250 mM LiCl, pH 7.0. All the titrations were performed at
25 M protein concentration. Increasing aliquots of TelG4-
up, TelG4-uh and TelG4-tp (to reach concentrations of
0.25, 0.5, 1, 2, 25 M) have been added to the HMGB11–166
protein solution. Titrations of the isolated box domains
were performed only with TelG4-up, by adding increasing
amounts of DNA to the box-A (to reach concentrations of
0.25, 0.5, 1, 2, 4, 25 M) and box-B (to reach concentrations
of 0.25, 0.5, 1, 2, 12.5, 25 M) solutions. At the end of box-
B titration, a solution of box-A was added to the final box-
B/TelG4-up solution to obtain a box-A/box-B/TelG4-up
mixture in the 1:1:1 molar ratio. The effects have been mon-
itored through 2D 1H–15N HSQC NMR (1H spectral win-
dow = 15 ppm; 15N spectral window = 35 ppm; relaxation
delay = 1.2 s; number of scans = 32; number of points in F1
dimension = 128). The NMR titrations of the HMGB11–166
protein and isolated box-A were performed also in the pres-
ence of the well-known G4 ligands Braco-19 (31) or RHPS4
(32). The ligand (2.5 mM) was first added to the protein
solutions; then, increasing amounts of TelG4-up (0.25, 0.5,
1, 2, 4, 8 M) were added. For box-A, the effects of the
equimolar concentration of TelG4-up (25 M) in the pres-
ence of Braco-19 were also analyzed. The spectra were col-
lected on Bruker Advance III NMR spectrometers operat-
ing at 900 and 950 MHz, 1H Larmor frequencies, processed
with the Bruker’s TopSpin software and analyzed using the
software CARA (33). The protein assignment was based
on the data reported in the Biological Magnetic Resonance
Data Bank (34) under the accession code 11147.
Fluorescence titrations
Fluorescence titration experiments were performed at 25◦C
on a FP-8300 spectrofluorometer (Jasco) equipped with a
Peltier temperature controller system (Jasco PCT-818). A
sealed quartz cuvette with a path length of 1 cm was used.
Titrations were carried out by stepwise addition (5 l) of
a G4 DNA solution (150–200 M) to a cell containing a
fixed concentration of HMGB11–166 solution (3–4 M) in
10 mM KH2PO4 and 70 mM KCl, at pH 7.0. Experiments
were performed in the presence of Braco-19 or RHPS4 (1:1
ligand/DNA). Protein was excited at 280 nm, and emission
spectra were recorded between 285 and 500 nm. Both exci-
tation and emission slit widths were set at 5 nm. After each
G4 addition, the solution was stirred and allowed to equili-
brate for 5 min before spectrum acquisition. The fraction of
bound protein (α) at each point of the titration was calcu-
lated following the changes of fluorescence intensity at 327
nm, using the following relationship:
α = I327 − I
f ree
327
Ibound327 − I f ree327
where I327 is the fluorescence intensity at the various
protein/DNA ratios investigated; I f ree327 and I
bound
327 are the
fluorescence intensities of the free and fully bound protein,
respectively. Titration curves were obtained by plotting α
versus the G4 concentration. The equilibrium dissociation
constant (Kd) and the stoichiometry of interaction were es-
timated from this plot by fitting the resulting curve, us-
ing nonlinear regression, to an independent and equivalent
binding site model as previously described (35). The pro-
tein concentration was corrected for dilution effects result-
ing from the change in volume due to DNA solution addi-
tion.
Surface plasmon resonance (SPR) experiments
SPR experiments were performed on a Biacore X100
(GE Healthcare), using a research-grade CM5 sensor
chip. HMGB11–166 protein was immobilized using amine-
coupling chemistry and HBS-EP as running buffer (HEPES
10 mM, NaCl 150 mM, EDTA 3 mM, 0.005% surfactant
P20, pH 7.4). The surfaces of flow cells were activated
with a 1:1 mixture of 0.1 M NHS (N-hydroxysuccinimide)
and 0.1 M EDC (3-(N,N-dimethylamino)propyl-N-
ethylcarbodiimide) at a flow rate of 10 l/min. The protein
at a concentration of 50 g/ml in 10 mM sodium acetate,
pH 4.5, was immobilized on the sample flow cell, leaving
the reference cell as blank. Unreacted activated groups
were blocked by injection of 1.0 M ethanolamine at 10
l/min over the chip surface. DNA samples were injected
at 25◦C at various concentrations (from 2 to 32 M), using
10 mM KH2PO4 buffer (pH 7.0) containing 70 mM KCl as
running solution. Injections were performed at a flow rate
of 30 l/min, with association and dissociation times of 80
and 600 s, respectively. The sensor surface was regenerated
by using 10 mM NaOH for 12 s. Data were fit to a simple
1:1 kinetic interaction model, using the global data analysis
option available within the Biacore Evaluation software
provided with the instrument.
Modeling of the complexes of HMGB1 with TelG4-up
The models of the complex between either the isolated box
domains or the HMGB11–166 protein and the human telom-
eric G4 were obtained by performing docking calculations
with the software HADDOCK 2.2 (36) on the WeNMR
GRID (http://www.wenmr.eu) (37) using the Guru inter-
face. In all calculations, during the rigid-body docking,
1000 complexes were generated, then 200 structures were
selected for the semi-flexible simulated annealing in torsion
angle space, and finally refined in Cartesian space with ex-
plicit solvent. The first model of HMGB1 NMR structures’
family (PDB code: 2YRQ) provided the input coordinates
for both the HMGB11–166 protein and the single domains
(box-A residues: K7-P81; box-B residues: N93-G166). As
input coordinates for unimolecular parallel telomeric G4
(TelG4-up), the PDB 2LD8 structure, formed by the 23-mer
d[TAGGG(TTAGGG)3] sequence (38), was used in the cal-
culations. In the docking calculations of box-A with TelG4-
up, the residues identified during the NMR titration of this
isolated domain were ambiguously restrained to either the
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the residues of the first two loop regions of the G4 (T6,
T7, A8, T12, T13, A14). For box-B, no specific region of
interaction could be identified in the NMR titration of the
isolated domain; thus, the residues of box-B experiencing
the highest decrease of signal intensity in the titration of
HMGB11–166 were ambiguously restrained to the third G-
tetrad plane (residues G5, G11, G17, G23). In the multi-
body docking calculations, box-A and box-B were simulta-
neously docked on TelG4-up using the interacting residues
previously selected for the calculations of the two separated
domains; box-A was docked either on the third G-tetrad
plane (residues G5, G11, G17, G23) or on the loop re-
gion (residues T6, T7, A8, T12, T13, A14), while box-B was
docked on the first G-tetrad plane (residues G3, G9, G15,
G21). The best water-refined HADDOCK models showing
a distance between the two domains compatible with the
length of the linker connecting the two domains, were se-
lected as input templates to Modeller (39) to re-build the
linker between box-A and box-B. The obtained models were
then subjected to a further refinement protocol in HAD-
DOCK and scored according to the HADDOCK-scores.
Immunofluorescence
Cells were fixed in 2% formaldehyde in phosphate buffered
saline (PBS) for 10 min at room temperature (RT) and
permeabilized in 0.25% Triton X-100 in PBS for 5 min at
RT. For immune-labeling, cells were incubated with pri-
mary antibody for 2 h at RT, washed twice in PBS and
finally incubated with the secondary antibodies for 1 h.
The following primary antibodies were used: Rabbit pAb
anti-HMGB1 (Abcam Ltd, Cambridge, UK), Mouse mAb
anti-H2AX (Millipore, Billerica, MA, USA) and Rab-
bit pAb anti-TRF1 N19 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA). The following secondary antibodies were
used: Anti-Mouse IgG (H+L), F(ab’)2 Fragment (Alexa
Fluor 488 Conjugate) (Cell Signaling) and Anti-rabbit IgG
(H+L), F(ab’)2 Fragment (Alexa Fluor 555 Conjugate)
(Cell Signaling). Nuclei were stained with 4′,6-diamidino-
2-phenylindole (DAPI, Sigma). Fluorescence signals were
recorded by using a Leica DMIRE2 microscope equipped
with a Leica DFC 350FX camera and elaborated by Le-
ica FW4000 deconvolution software (Leica, Solms, Ger-
many). For quantitative analysis of H2AX positivity, 300
cells on triplicate slices were scored and for TIF analysis, 30
H2AX-positive cells were scored. Cells with at least four
co-localizations (H2AX/TRF1) were considered as TIF-
positive. Where reported, cells were incubated with the in-
dicated doses of Braco-19 for 24 h.
Western blotting
Western blot analysis was performed as previously reported
(40). Expression levels of HMGB1 were evaluated by using
the Rabbit pAb anti-HMGB1 (Abcam Ltd). Actin signal
was detected by Mouse mAb anti--actin (Sigma Aldrich)
and used as loading control.
Chromatin immunoprecipitation assay (ChIP)
Formaldehyde-cross-linked chromatin fragments obtained
from HeLa cervical cancer cells were immunoprecipitated
with Rabbit pAb anti-HMGB1 (Abcam Ltd.) and with
Rabbit pAb anti-TRF1 N19 (Santa Cruz Biotechnology) as
positive control for telomeric sequences. Chromatin frag-
ments immunoprecipitated without the antibody (No Ab)
and with Normal Rabbit immunoglobulins (IgG) (Santa
Cruz Biotechnology) were used as negative controls of the
ChIP assay. After precipitation, the assay was performed as
previously described (41).
RESULTS
Protein purification and assignment of protein residues
HMGB11-166, box-A, and box-B were expressed as fu-
sion proteins containing a N-terminal GST (glutathione-
S-transferase) tag that allows an easy purification by using
standard TEV protease-based methods (see Materials and
Methods). The identity and purity of the samples were then
ascertained by SDS-PAGE analysis of the purified proteins
(Supplementary Figure S4, Supplementary Material). The
2D 1H–15N HSQC NMR spectrum of HMGB11-166 showed
that the purified protein was correctly folded (Supplemen-
tary Figure S5, Supplementary Material). Moreover, the
cross-peaks of the isolated box-A and box-B overlaid well
with the spectrum of the N-terminal and C-terminal re-
gions of HMGB11–166, respectively (Supplementary Fig-
ure S6, Supplementary Material), thus indicating that they
adopted their native conformation as in the entire protein.
The chemical shift assignments obtained from the BMRB
entry 11147 were directly mapped to the 2D 1H–15N HSQC
spectra of the HMGB11-166 protein and of the isolated do-
mains, allowing us to detect the protein regions involved in
the G4 DNA recognition.
CD characterization of the investigated G-quadruplexes
G-rich human telomeric motifs can, in the presence of K+,
fold into different G4 topologies depending on the sequence
and experimental conditions (42). Since several studies sug-
gest that the parallel G4 fold is prevalent in the overcrowded
conditions of cells (26,38), and given that this conforma-
tion is the one used as a probe to fish out HMGB1 from a
nuclear protein matrix (11), we selected it as the main can-
didate for studying HMGB1/G4 interaction. Therefore, we
prepared a d[(TTAGGG)4TT] sample at high DNA concen-
tration conditions in order to promote the formation of the
unimolecular parallel G4 conformation (43), characterized
by the presence of three double-chain-reversal loops run-
ning along three of the four grooves having the same width
(TelG4-up, Figure 1A) (38).
To investigate the HMGB1 binding properties to differ-
ent telomeric G4s, we also prepared a d[(TTAGGG)4TT]
sample at low concentration in which it is expected to
form the so-called hybrid [3+1] fold as major conformation,
characterized by mixed parallel/antiparallel G-strands, one
double-chain-reversal and two lateral loops, and grooves
of different width (TelG4-uh, Figure 1B) (44). Finally, we
also considered the tetramolecular G4 structure formed
by the short d(TTAGGGT) truncation, having all parallel-
oriented strands and no loops (TelG4-tp, Figure 1C) (45).
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Figure 2. CD spectra of (A) TelG4-up, (B) TelG4-uh and (C) TelG4-
tp G4s (1 M) (black lines), HMGB11–166 (1 M) (blue lines), and 1:1
G4/HMGB11–166 mixtures (gray lines). The spectra derived from the arith-
metical sum of the individual spectra of G4s and HMGB11-166 are reported
as well (cyan lines).
tures differing in the presence/absence or conformation of
loops, and in the width or accessibility of grooves.
The folding adopted by each G4 sample was verified by
CD spectroscopy, a well-established technique for deter-
mining the presence and the overall topology of G4 struc-
tures (46). TelG4-up and TelG4-tp showed very similar CD
spectra, with a positive band at 264 nm and a negative band
at ∼240 nm (Figure 2), characteristic of the parallel G4
conformations. On the other hand, TelG4-uh showed a CD
spectrum with two positive bands at 290 and 268 nm, and
a weak negative band at ∼240 nm (Figure 2), in agreement
with the hybrid G4 folding topology. CD melting experi-
ments were also performed to get information on the sta-
bility of the investigated G4s (Supplementary Figure S7,
Supplementary Material). The thermal denaturation of G4s
was monitored at the wavelength of maximum CD inten-
sity, i.e. 264 nm for TelG4-up and TelG4-tp, and 290 nm
for TelG4-uh. The melting experiments showed sigmoidal
transition curves still indicative of the formation of the
structures, while the melting temperatures (Tm) obtained
from the curve fitting were 65.6 (±1.0), 54.8 (±0.5) and
61.8 (±0.5)◦C for TelG4-up, TelG4-uh and TelG4-tp, re-
spectively. These data are in agreement with the previously
published results for these DNA molecules in the same ex-
perimental conditions (11,47).
HMGB11–166 and box-A do not induce the unfolding of telom-
eric G4s
The CD spectra of the proteins (HMGB11–166 or box-A)
alone, as well as those of G4/protein (1:1 molar equiv.) mix-
tures, were also recorded and are shown in Figure 2 and
Supplementary Figure S7A–C, along with the spectra re-
sulting from the arithmetic sum of the spectra of the sin-
gle components. In all cases, no significant changes were
observed in the spectral region where only the G4 chro-
mophores absorb ( > 245 nm), clearly indicating that
no unfolding or structural alterations of DNA secondary
structures occur in the presence of the HMGB11-166 protein
or the box-A domain. Within the 190–245 nm wavelength
range, despite no considerable variations between the ex-
perimental and the corresponding calculated DNA/protein
spectra, such spectra differ to a certain extent from each
other, thus suggesting the DNA–protein interaction.
Furthermore, to evaluate any possible
stabilizing/destabilizing effect of HMGB11–166 and
box-A on the investigated G4s, CD melting experiments
were carried out (Supplementary Figure S7D–F, Supple-
mentary Material). Upon HMGB11-166 addition to the G4
solutions, CD melting curves showed a slight increase in
the thermal stability of the DNA structures (Tm = 2.9
(±0.7)◦C and 2.3 (±0.7)◦C for TelG4-uh and TelG4-tp,
respectively). It is to be noted that the melting profile of
TelG4-up in the presence of HMGB11–166 exhibits two
inflection points (probably because of the formation of
some aggregates besides the DNA/protein complex), a
first one at around 53◦C, and a second one at around
72◦C (with a Tm of ∼6.5◦C compared to the G4 alone).
Quite different effects on the thermal stability of G4s were
observed in the presence of box-A. When it was added
to TelG4-uh and TelG4-tp solutions, no changes in the
thermal stability of these DNA structures were observed.
On the other hand, a significant increase of the stability of
TelG4-up was observed in the presence of box-A (Tm =
4.7 (±1.0)◦C), thus suggesting a probable pivotal role of
box-A in the interaction with this G4.
NMR investigation of HMGB11-166 binding to TelG4-up,
TelG4-uh and TelG4-tp
The region of the HMGB11–166 protein surface involved in
the interaction with G4 molecules has been investigated by
monitoring the changes in cross-peak intensity ratio (I/I0),
as well as the chemical shift variations () occurring in the
2D 1H–15N HSQC spectrum of the uniformly 15N-labeled
protein upon the addition of increasing amounts (to reach
concentrations of 0.25, 0.5, 1, 2, 25 M) of each G4-forming
DNA (I), versus the free protein in solution (I0). The con-
centration of the protein used for the NMR titrations was
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Figure 3. (A) Per residues intensity changes and (B) chemical shift pertur-
bation of HMGB11-166 protein (25 M) in the presence of 1 M TelG4-up
DNA. The residues exhibiting the largest effects have been colored in red
(A) and green (B) on the structure of free HMGB1 (pdb: 2YRQ).
trations, protein-DNA aggregation caused extensive precip-
itation upon addition of DNA. To be sure that our results
were not affected by non-specific aggregation phenomena,
we analyzed in detail the effects measured at low concentra-
tions of the DNA molecules, i.e. upon the addition of 1 M
TelG4-up (Figure 3A and Supplementary Figure S8, Sup-
plementary Material). The affected residues (Table 1) were
distributed on both domains.
Analogous titrations were performed for TelG4-uh and
TelG4-tp, whose effects on the HMGB11–166 spectrum are
shown in Supplementary Figures S9 and S10 (Supplemen-
tary Material), respectively. Also for these systems, we mea-
sured the effect of DNA on the protein NMR spectrum at
1 M G4 concentration. The observed changes in signal in-
tensity and/or chemical shift variations, indicating an inter-
action in the intermediate regime on the NMR timescale,
are summarized in Table 1 and Supplementary Figures S9
and S10 in the Supplementary Material.
Overall, these results clearly demonstrated that
HMGB11-166 interacts with the three subtypes of telomeric
G4s. In particular, it seems that box-A involvement in the
interaction is more extensive than that of box-B (Table 1).
While a single interaction region could not be identified,
the sequence stretches from residue 20 to 25, and from
residue 35 to 45 were the major perturbed sites.
Braco-19 affects but does not prevent the binding of
HMGB11-166 to TelG4-up, TelG4-uh and TelG4-tp
To shed light on the structural determinants of G4 recog-
nition by HMGB1, competitive NMR binding studies in
the presence of the well-known G4-binding ligand Braco-
19 were carried out. The trisubstituted acridine Braco-19
is known to bind to the external G-tetrad planes of G4s
through stacking interactions with a Kd of about 3.2 × 10−8
M (31,48), so it was expected to affect or even prevent the
binding of HMGB1 if occurring at the G-tetrads. Prelimi-
narily, Braco-19 was added to the protein to evaluate any
possible interaction with HMGB1. In this respect, only mi-
nor effects were observed even at a protein/ligand ratio of
1:100 (Supplementary Figure S11, Supplementary Mate-
rial).
HMGB11-166 (25 M) was titrated with increasing
amounts of TelG4-up, TelG4-uh and TelG4-tp (from
0.25 up to 25 M) in the presence of Braco-19 (2.5 mM).
For all systems, the presence of Braco-19 considerably di-
minished the widespread effect of G4s on the cross-peaks of
HMGB1 (I/I0 values were on average closer to 1), thus indi-
cating a significant reduction of the protein-DNA interac-
tion, likely preventing concatenate protein/DNA aggrega-
tion. This was particularly evident for TelG4-up where the
residues mainly affected by DNA interaction were all in the
box-A domain (F19, E25, K28, K30, H31, E40, E47, M52,
A54, K55, E56, K57, G58, A64, E74, M75) (Figure 4A and
Supplementary S12A, Supplementary Material), with some
closely located residues exhibiting chemical shift perturba-
tions (V20, S35, K59, Figure 4B and Supplementary Figure
S12B, Supplementary Material). However, an interaction in
the intermediate regime on the NMR timescale is substan-
tially maintained.
As far as TelG4-uh and TelG4-tp are concerned, even
though the general decrease in the intensity of HMGB1
cross-peaks was reduced in the presence of Braco-19, the
perturbed few residues were scattered along the whole pro-
tein sequence, suggesting a non-specific interaction.
Overall, these results show that Braco-19 affects but does
not prevent the binding of HMGB1 to telomeric G4s in
vitro, and suggest a major role for box-A, at least in the in-
teraction with TelG4-up.
To further investigate the role of the G-tetrad planes of
G4s in the binding to HMGB1, the effects of a second G4-
binding ligand, RHPS4, on HMGB11-166/G4s interaction
were evaluated performing new competitive NMR bind-
ing studies. HMGB11-166 (25 M) was thus titrated with
increasing amounts of TelG4-up, TelG4-uh and TelG4-tp
(from 0.25 up to 25 M) in the presence of the same high
excess of ligand (2.5 mM). In these conditions, the effects
of telomeric G4s on the protein NMR signals were weaker
than those observed when Braco-19 was present in solu-
tion and became significant only at higher DNA concentra-
tions. The perturbed residues, also for TelG4-up, were scat-
tered along the whole protein sequence, even if with larger
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S42 X











M63 X X X
K65 X
D67 X X
E72 X X X
E74 X X
T77 X X X





















I159 X X X
A160 X
R163 X
A164 X X X
K165 X X
*Residues of box-A and box-B domains are in bold. Significantly decreased residues displayed a change in intensity deviating more than 1  from the
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Figure 4. (A) Per residues intensity changes and (B) chemical shift pertur-
bation of HMGB11-166 protein (25 M) in the presence of 1 M TelG4-up
DNA and Braco-19 (2.5 mM). The residues exhibiting the largest effects
have been colored in red (A) and green (B) on the structure of free HMGB1
(pdb: 2YRQ).
NMR investigation of the interaction of isolated box-A and
box-B domains with TelG4-up in the absence and presence of
Braco-19
To better define the regions of HMGB1 involved in the in-
teraction and shed light on the mechanism of G4 recogni-
tion, we performed NMR titrations of the two isolated box
domains (A and B) with TelG4-up.
As in the case of the HMGB11–166 protein, the effects
of the DNA G4 on box-A were already visible after the
addition of very low amounts of nucleic acid molecule (1
M). The residues with the highest decrease in signal in-
tensity are placed in the short arm of the L-shaped struc-
ture (Table 2, Figure 5A and Supplementary Figure S14A,
Supplementary Material) with few neighboring residues ex-
hibiting a small chemical shift perturbation (Figure 5B and
Supplementary Figure S14B, Supplementary Material). At
higher concentrations of TelG4-up (2 < [C] < 25 M) the
protein signals completely disappeared because of extensive
line broadening, possibly due to aggregation processes oc-
curring also between the isolated box-A and the DNA.
On the other hand, the effect of TelG4-up on the isolated
box-B domain was found to be less significant than those
observed for box-A and HMGB11-166, and higher concen-
tration of G4 were allowed in solution without having the
complete disappearance of the signals from the 2D 1H–15N
Figure 5. (A) Per residues intensity changes and (B) chemical shift per-
turbation of box-A domain of HMGB1 (25 M) in the presence of 1
M TelG4-up DNA. The residues exhibiting the largest effects have been
colored in red (A) and green (B) on the structure of free HMGB1 (pdb:
2YRQ).
HSQC spectrum. The residues with the highest decrease
in signal intensity at equimolar concentration (25 M) of
TelG4-up and box-B (Table 2) are spread on a wide protein
surface, preventing the identification of a specific binding
region (Supplementary Figure S15, Supplementary Mate-
rial). Moreover, no significant chemical shift perturbations
were observed. Intriguingly, after adding the isolated box-
A domain to the solution containing the TelG4-up/box-B
mixture, an extensive further decrease of box-B signal in-
tensities was observed (Figure 6 and Supplementary Figure
S16, Supplementary Material), thus indicating that the in-
teraction of box-B with the G4 was greatly favored by the
presence of box-A, possibly because of a cooperative bind-
ing of the two domains and/or by aggregation induced phe-
nomena.
In addition, we also investigated the interaction of the
box-A domain with TelG4-up in the presence of Braco-19
(2.5 mM). As observed for the HMGB11-166 protein (Figure
4A and Supplementary Figure S12A, Supplementary Ma-
terial), the overall effects are weakened in the presence of
the G4 ligand and the residues with the highest decrease in
signal intensity (T22, H27, K28, K30, H31, E40, K43, K50)
were located on a smaller region of the protein surface (Fig-
ure 7A and Supplementary Figure S17A, Supplementary
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perturbation Residue* Intensity decrease
Chemical shift
perturbation
M13 X F103 X
S14 X F105 X
Y16 X S107 X
F18 X E108 X
F19 X Y109 X
V20 X R110 X
Q21 X K112 X
T22 X K114 X
E26 X E116 X
H27 X G119 X
K30 X K128 X
H31 X Y144 X
D33 X E145 X
A34 X L151 X
F41 X E153 X
S42 X K154 X
K43 X E156 X
C45 X X D158 X
S46 X A160 X









*Significantly decreased residues displayed a change in intensity deviating more than 1  from the average variation observed over the entire sequence.
Figure 6. Per residues intensity changes of box-B after the addition of box-
A (25 M) to the complex box-B/TelG4-up (25 M). The residues ex-
hibiting the largest effects have been colored in red on the structure of free
HMGB1 (pdb: 2YRQ).
perturbation (E26, K55, F60, T77, Figures 7B and S17B,
Supplementary Material). The interaction of box-A with
TelG4-up was investigated also in the presence of RHPS4
(2.5 mM). As previously observed with HMGB11-166, the ef-
fects of TelG4-up on the box-A NMR signals were weaker
than those observed when Braco-19 was present in solution.
(Supplementary Figure S18, Supplementary Material).
Evaluation of binding affinity by fluorescence titration and
SPR experiments
The binding of HMGB11-166 to the telomeric G4s was ex-
amined by fluorescence titration and SPR experiments. Flu-
orescence experiments were carried out by monitoring the
changes in the intrinsic fluorescence of the protein upon
binding to DNA (16). Fluorescence emission spectra of
HMGB11-166 were recorded upon addition of increasing
amounts of each G4. Titrations were performed in the
presence of Braco-19 (1:1 ligand/DNA), after excluding
protein/drug interactions, to avoid protein-DNA aggrega-
tion phenomena in solution that would be detrimental to
the experiments. As clearly shown in Figure 8A–C, a sig-
nificant decrease in fluorescence intensity on increasing the
concentration of G4s was observed. The titration curves
(Figure 8D) were fitted by means of nonlinear regression al-
gorithm using an independent and equivalent binding sites
model (35), to get the equilibrium dissociation constants
(Kd). From these fittings, Kd values of 4.2 (±0.3) × 10−7, 6.0
(±0.7) × 10−7 and 7.0 (±0.9) × 10−7 M were determined
for TelG4-up, TelG4-uh and TelG4-tp, respectively. These
results indicate that HMGB11-166 interacts with all three
G4s, showing a preference for the unimolecular parallel-
stranded TelG4-up. For comparison, fluorescence titrations
were also carried out in the presence of the G4 binder
RHPS4 (after excluding protein/drug interactions). As in
the first set of experiments, increasing the concentration of
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Figure 7. (A) Per residues intensity changes and (B) chemical shift pertur-
bation of box-A domain protein (25 M) in the presence of 1 M TelG4-up
DNA and Braco-19 (2.5 mM). The residues exhibiting the largest effects
have been colored in red (A) and green (B) on the structure of free HMGB1
(pdb: 2YRQ).
sity of HMGB11-166 until saturation was reached (Supple-
mentary Figure S19, Supplementary Material), thus indi-
cating the formation of protein/DNA complexes also in this
case. The Kd values obtained from fitting (5.7 (±0.5) × 10−7,
6.8 (±0.7) × 10−7 and 7.2 (±0.8) × 10−7 M for TelG4-up,
TelG4-uh and TelG4-tp, respectively) suggest that RHPS4
slightly decreases the affinity of HMGB11–166 for the G4s.
To get further insights into the kinetics and affinity of
these interactions, SPR experiments were performed. Rep-
resentative SPR sensorgrams obtained for the interaction
of immobilized HMGB11-166 with TelG4-up and TelG4-uh
are shown in Figure 8E and F, whereas no reliable SPR data
were obtained for TelG4-tp, probably due to the occurrence
of non-specific interactions. On the other hand, SPR exper-
iments on TelG4-up and TelG4-uh showed a response pro-
portional to DNA concentration, indicative of a specific in-
teraction with the protein. The association (kon) and dis-
sociation (koff) rate constants were derived from the fitting,
and the binding dissociation constants (Kd) were kinetically
determined. Kd values of 4.3 (±0.2) × 10−7 and 8.2 (±0.3)
× 10−7 M were obtained for TelG4-up and TelG4-uh, re-
spectively, in close agreement with fluorescence data. The
comparison of kinetic constants obtained for TelG4-up and
TelG4-uh reveals that koff values are similar for the two sys-
tems (1.62 (±0.03) × 10−3 and 1.26 (±0.02) × 10−3 s−1, re-
spectively), while kon value was greater for TelG4-up (3.81
(±0.08) × 103 M−1 s−1) than for TelG4-uh (1.54 (±0.03) ×
103 M−1 s−1), thus suggesting that the difference in affinity
arises from the association rates.
Calculation of the structural models of HMGB1/TelG4-up
complex
Docking calculations were performed using the software
HADDOCK to obtain 3D structural models describing the
interaction mechanism of HMGB1 and TelG4-up. The two
isolated domains were first separately docked in distinct cal-
culations on the DNA G4 structure. Since the interaction
of box-A is not inhibited in the presence of the G4 binder
Braco-19, two possible binding regions on TelG4-up were
hypothesized for this domain: (i) with the G-tetrad plane
and (ii) with the loops. Conversely, since the interaction of
box-B is completely hindered by the presence of Braco-19,
the G-tetrad plane was considered as the only binding re-
gion for this protein domain.
Two different sets of docking calculations were per-
formed for the isolated box-A: (i) on the loops of the G4
structure (residues T6, T7, A8, T12, T13, A14), consider-
ing as interacting residues the amino acids experiencing a
decrease in signal intensity during the titration performed
in the presence of Braco-19; (ii) on the G-tetrad plane
(residues G5, G11, G17, G23), considering as interacting
residues the amino acids experiencing a decrease in signal
intensity during the titration performed in the absence of
Braco-19, but those interacting in the presence of Braco-
19. In the first set (i), three different calculations (one for
each loop of the TelG4-up interacting with box-A) were
performed (Supplementary Figure S20A, panels I-III, and
Supplementary Table S1, Supplementary Material). Imme-
diately after, the case of box-A interacting at the same time
with two loops of TelG4-up was analyzed by HADDOCK.
The analysis of docking calculations where box-A interacts
with loops I–II and II–III, respectively is summarized in
Supplementary Figure S20A, panels IV–V, and Supplemen-
tary Table S1.
Conversely, a single docking calculation was performed
to investigate the interaction of box-A with the G-tetrad
plane of TelG4-up (set ii). The calculation provided multiple
clusters with equivalent HADDOCK-statistics (see Supple-
mentary Figure S20B and Supplementary Table S2, Sup-
plementary Material). A deeper inspection of the models
shows that each cluster (Supplementary Figure S20B-II-
III-IV), except one (Supplementary Figure S20B-I), dif-
fers from the other only for a symmetric rotation of box-A
around the DNA structure, while maintaining the protein
interface region.
Similarly, the docking of box-B on the G-tetrad plane
(residues G5, G11, G17, G23) provided many different clus-
ters which, however, can be grouped in two distinct binding
modes (Supplementary Figure S20C and Supplementary
Table S3). The first (panels I and II, Table S3, I–II) exhibits a
lower HADDOCK-score. The second binding mode shows
a higher HADDOCK-score but with a lower violation of
the experimental restraints (panels III and IV, Table S3, III–
IV). In all the models the hydrophobic residues of the short








ento di Sanità pubblica-U
niversità di Firenze user on 07 N
ovem
ber 2019
Nucleic Acids Research, 2019, Vol. 47, No. 18 9961
Figure 8. (A–C) Fluorescence emission spectra of HMGB11–166 (3 M) in the absence and presence of stepwise addition (5 l) of (A) TelG4-up, (B)
TelG4-uh, and (C) TelG4-tp G4s at 25◦C. (D) Titration curves obtained by plotting the fraction of bound protein (α) versus the DNA concentration for
TelG4-up (black), TelG4-uh (red), and TelG4-tp (green).The circles represent the experimental data, the lines are the best fit obtained with the theoretical
model. (E, F) Time evolution SPR sensorgrams obtained at 25◦C by injections of (E) TelG4-up and (F) TelG4-uh at various concentrations on the chip-
immobilized HMGB11-166 with a contact time of 80 s, a dissociation time of 600 s, and a flow rate of 30 l/min. The sensorgrams are shown as colored
lines and their respective fits, based on the 1:1 kinetic interaction model, as black lines.
tetrad plane. At the same time, the C-terminal residues of
the protein interact with the DNA phosphate groups. It is
interesting to point out that the hydrophobic residues F103
and I122, belonging to box-B and crucial for the interaction
with duplex DNA (24), here interact with the G4-forming
DNA.
Firstly, to investigate the binding mode of the
HMGB11-166 protein to TelG4-up, the simultaneous
binding of the two boxes to the G4 was analyzed. This is
in agreement with our experimental data where the inter-
action of box-B with TelG4-up occurs only in the presence
of box-A. Therefore, multibody docking calculations were
performed considering: i) the interaction of the isolated
box-A and box-B with two different G-tetrad planes of
the same DNA molecule (model A), ii) the interaction
of the isolated box-A with the loop region of TelG4-up
and of isolated box-B with one G-tetrad plane (model B).
Each of the two distinct docking calculations provided
many different clusters, which were selected taking into
account the experimental NMR data and the length of the
linker connecting box-A and box-B in the HMGB1 protein,
which was generated with Modeller program (39) after each
docking calculation. The models of the HMGB1/TelG4-
up complexes obtained by Modeller, starting from the
HADDOCK clusters, were further refined with HAD-
DOCK. The models with the best HADDOCK scores are
shown in Supplementary Figures S21–S22 (Supplementary
Material) and the docking statistics reported in Table S4.
The docking complexes with the lowest HADDOCK-score
(for model A and model B, respectively) are shown in
Figure 9. The best calculated complex for model A, where
HMGB1 sandwiches the DNA construct, has a lower
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Figure 9. Best first models of HMGB11-166 and TelG4-up obtained per-
forming multi-body docking calculations, with the software HADDOCK
(see main text), and considering in one case the interaction of box-A with
the G-tetrad plane (model A) and in the other case the interaction with
the loop (model B). The interaction of box-B is with the G-tetrad plane in
both cases. Box-A is in blue, box-B in marine, TelG4-up in yellow, and the
‘active’ residues in the two domains as magenta spheres.
Biological analyses
Finally, to define the biological relevance of the obtained re-
sults, we extended our study to tumor cell lines. Based on the
data described above, we first evaluated whether HMGB1
localizes at telomeres in both telomerase positive cells and
in cells lacking telomerase activity (telomerase negative
cells), in which the telomere length is maintained through
homologous recombination dependent mechanisms (ALT
cells). To this aim, HeLa cells––a telomerase positive
cervical carcinoma cell line with short telomeres––and
U2OS––an ALT osteosarcoma cell line with longer telom-
ers – underwent to immunofluorescence (IF) microscopy.
Notably, we found that, in both the cell lines analyzed,
HMGB1 colocalize with TRF1––an effective marker for
interphase telomeres––indicating that, independently from
telomere length and from the mechanism of telomere main-
tenance, HMGB1 is largely associated with telomeres (Fig-
ure 10A). In parallel with the IF experiments, the telom-
eric localization of HMGB1 was further confirmed in HeLa
cells by chromatin immunoprecipitation (ChIP) assay by
using a telomeric probe (Figure 10B). The enrichment of
TRF1 protein at telomeres was used as positive control of
Telo-ChIP. Moreover, additional IF experiments performed
in U2OS evidenced that the treatment of the cells with
Braco-19, at doses able to induce DNA damage (Supple-
mentary Figure S23, Supplementary Material), does not af-
fect significantly the amount of HMGB1 localized at telom-
eres (Figure 10C), consistent with the results of the biophys-
ical studies.
Next, moved by the observation of the telomere local-
ization of HMGB1, we questioned whether this protein
could play a role in the maintenance of telomere integrity.
To address this point, HeLa and U2OS cells were trans-
fected with a siRNA against HMGB1 (siHMGB1), or a
non-targeting control (siControl), and the effect of gene si-
lencing on DNA damage response (DDR) was evaluated by
IF analyses (Figure 11). Interestingly, the down-regulation
of HMGB1, verified by western blotting (Figure 11A), de-
termined a substantial increase of the phosphorylated form
of H2AX (H2AX), a hallmark of DNA double-strand
breaks (Figure 11B). Moreover, several of the damage spots
induced by the silencing of HMGB1 were found to co-
localize with TRF1, indicating that HMGB1 plays a critical
role in telomere maintenance (Figure 11C). In particular,
the quantitative analysis performed by measuring the num-
ber of telomere-induced foci (TIFs) deriving from the colo-
calization between H2AX and TRF1, revealed that silenc-
ing of HMGB1 determines a significant increase in both the
percentage of TIF positive cells (cells with at least four co-
localization spots) and the average number of TIFs per cell
(Figure 11D and E). Notably, a number of non-telomeric
H2AX foci were also observed in HMGB1 silenced cells,
suggesting that this protein, probably interacting with other
G4 structures present in the genome (49), may play a more
general role in the maintenance of DNA integrity.
DISCUSSION
The G4s represent one of the most significant nucleic acid
secondary structures involved in the regulation of various
cellular processes. For appropriate biological function, the
formation, stabilization, and resolution of G4s need to be
regulated in a tight spatiotemporal manner (50). In this
frame, G4 recognition and processing by nucleic acid di-
rected proteins represent a key event to activate or deac-
tivate physiological or pathological pathways (51,52). In
the telomeric region, where G4s have been shown to have
key regulatory roles in telomere extension and maintenance
(53), an ensemble of interacting proteins is involved in the
modulation of the telomere end-conformation and, thus, in
the modification of its homeostasis (50,52).
In the present study, to get insights into the telomeric
G4 DNA recognition by HMGB1 protein, we performed
detailed biophysical studies complemented with biological
analyses. Since there is controversy as to the exact confor-
mation of human telomeric G4 under physiological condi-
tions, and it has become increasingly apparent that the hu-
man telomeric sequence may be structurally heterogeneous,
we investigated both the parallel-stranded and the hybrid
[3+1] G4 structures formed by the d[(TTAGGG)4TT] trun-
cation of human telomeric DNA. In addition, to evalu-
ate a possible role of loops in the G4/protein recognition,
we analysed the tetramolecular G4 formed by the short
d(TTAGGGT) sequence that has no loops. CD experi-
ments, performed to further investigate the protein/DNA
interaction and monitor the unfolding or any possible
change in the G4 structure upon binding, showed that
no unfolding or structural alterations of DNA secondary
structures occur upon binding to HMGB1 or box-A. 3D
models of HMGB1/TelG4-up complex obtained by dock-
ing calculations driven by the experimental NMR data,
shed light on the possible interaction mechanism and high-
lighted the role of the G4 shape in protein–DNA recogni-
tion.
All the biophysical methodologies employed here (CD,
fluorescence, and NMR spectroscopy as well as SPR) pro-
vided evidence that HMGB1 interacts with the three sub-
types of telomeric G4s, but with some differences. The
NMR data provided evidence of a better interaction with
the unimolecular parallel-stranded TelG4-up and suggested








ento di Sanità pubblica-U
niversità di Firenze user on 07 N
ovem
ber 2019
Nucleic Acids Research, 2019, Vol. 47, No. 18 9963
Figure 10. HMGB1 localizes at telomeres. (A) To establish whether HMGB1 colocalizes with telomeres, telomerase-positive HeLa cells and telomerase-
negative/ALT-positive U2OS cells were processed for immunofluorescence using antibodies against the telomeric protein TRF1 (green) and HMGB1
(red). Nuclei are indicated by dotted lines. The images were acquired with a Leica Deconvolution microscope (magnification 63×). Enlarged views of co-
localization spots are reported. (B) Formaldehyde-cross-linked chromatin fragments, obtained from HeLa cells, were immunoprecipitated with antibodies
against HMGB1 and TRF1, as positive control for telomeric sequences. Chromatin immunoprecipitation with Rabbit immunoglobulins (IgG) and without
antibody were used as negative controls. To verify that an equivalent amount of chromatin was used in the immunoprecipitates, 0.5 and 0.05 g of the
total chromatin (Input) were included in the blot. Specific (Telo) and nonspecific (Alu) probes were used. (C) U2OS cells were treated with Braco-19 at the
indicated doses for 24 h and processed for IF analysis as in (A). Left panel: Representative immunofluorescence images. Right panel: Quantitative analysis
of HMGB1/TRF1 colocalization, expressed as the number of HMGB1/TRF1 colocalizations for cell. Histograms show the mean values ± S.D. of three
independent experiments.
binding region on box-A seems to be located mainly on the
concave surface of the short arm of the L-shaped structure
of the protein, on the same side of that involved in the in-
teraction with four-way junction DNA (54), but on the op-
posite side to that of DNA duplex binding (23). The bind-
ing studies in the presence of the G4 binders Braco-19 and
RHPS4 indicated that the ligands affect but do not pre-
vent the G4/protein interaction in vitro. This is in agree-
ment with the results of immunofluorescence analysis show-
ing that telomeric localization of HMGB1 is not dramat-
ically affected by the G4-binding compounds. Altogether,
our data suggest that the protein interacts with G4 DNA
also (but not only) in a region not involved in the binding
with Braco-19 and RHPS4. Considering that such ligands
bind to this DNA structure by stacking on the external G-
tetrad(s), it is plausible that HMGB1 also interacts with the
loops of G4. In summary, the experimental and computa-
tional studies reported here show that (i) the G4 architec-
ture is important for the HMGB1 recognition and (ii) the
structural determinants for a better interaction may also be
represented by the presence and specific conformation of
loops.
To gain insights into the energetic aspects of binding,
the interaction of HMGB1 with the three G4s was ex-
amined by fluorescence titration and SPR experiments.
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Figure 11. Knocking-down of HMGB1 induces telomere instability. HeLa and U2OS cells were transfected with a siRNA against HMGB1 (siHMGB1)
or a non-targeting siRNA (siControl) and assayed. (A) Representative western blot showing the expression levels of HMGB1 evaluated in HeLa and
U2OS cells, silenced or not (siControl) for HMGB1. Analysis of -actin was reported as loading control. (B–E) The indicated cell lines were processed for
immunofluorescence (IF) using antibodies against H2AX and TRF1 to visualize the DNA damage and telomeres, respectively. (B) Histogram showing
the percentage of H2AX-positive cells. (C) Representative images of IF microscopy experiments. H2AX spots are visualized in green, TRF1 in red and
nuclei are stained in blue. Enlarged views of Telomere Induced Foci (TIFs) are reported. The images were acquired with a Leica Deconvolution microscope
(magnification 63x). (D, E) Quantitative analysis of TIFs. The graphs represent the percentages of (D) TIF-positive cells and (E) the mean number of TIFs
per cell in the indicated samples. Cells with at least four H2AX/TRF1 foci were scored as TIF positive. Histograms show the mean values ± S.D.
protein/DNA interaction in the presence of Braco-19 or
RHPS4––confirmed the results obtained by NMR: (i) the
G4 ligands do not prevent the interaction and (ii) HMGB1
has a preference for the unimolecular parallel TelG4-up.
SPR results indicated a specific protein interaction for
TelG4-up and TelG4-uh, with a lower Kd for the former,
in agreement with fluorescence data. Overall, the biophysi-
cal data showed that the G4 structural variability may have
significant implications in protein recognition. Since the in-
vestigated G4 structures mainly differ in presence and con-
formation of loops, these results suggest an important role
for the double-chain-reversal loops of unimolecular parallel
G4 conformation in the interaction with HMGB1. Interest-
ingly, the Kd observed for HMGB1/TelG4-up interaction is
comparable to that found for the binding of this protein to
another parallel-stranded G4, namely the KRAS promoter
G4 (Kd of about 5 × 10−7 M) (16), thus suggesting that this
protein might have a more global effect as G4-interactor, be-
ing not selective for telomeric G4s. In addition, the affinity
for TelG4-up was also found to be similar to that previously
observed for the binding of HMGB1 to cisplatin-modified
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tude higher than that reported for the nonspecific binding
to B-form DNA (Kd of about 5 × 10−5 M) (56). The quan-
titative estimate of on/off rates of binding revealed that the
difference in affinity arises from the association rates. Note
that kon generally determines the binding affinity to a higher
extent than koff for proteins that bind with large conforma-
tional changes, whereas, for rigid complexes, koff is the ma-
jor determinant for binding affinity (57).
Regarding the biological relevance of such interactions, a
couple of studies have focused on the roles of HMGB1 in
telomere biology. Polanska et al. showed that knockout of
the HMGB1 gene in mouse embryonic fibroblasts (MEFs)
resulted in a decline in telomerase activity and telomere dys-
function, while overexpression of HMGB1 enhanced telom-
erase activity (18). Ke et al. demonstrated that the decreas-
ing HMGB1 levels promote telomere dysfunction and con-
fer radiosensitivity in human breast cancer cells (17). Our
biological data identified HMGB1 as a telomere-associated
protein in both telomerase-positive (HeLa) and telomerase-
negative (U2OS) tumor cell lines and showed that the silenc-
ing of HMGB1 encoding gene in such cells induces telom-
ere DNA damage foci. Even if we cannot exclude a broad
role of HMGB1 in maintenance of DNA integrity through
interaction with G4 structures interspersed in the genome
(49,58), our findings evidence that HMGB1 is indispensable
for telomere homeostasis and suggest that this protein could
actually represent a new target for cancer therapy. Over-
all, our data indicate that the relationship between HMGB1
and telomere biology, remained unclear until now, may de
facto be the G4 DNA structures.
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